Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1786 AL 1800

The neuromicrobiology of Parkinson's disease: A unifying theory

Munoz-Pinto MF, Empadinhas N, Cardoso SM.

Ageing Res Rev. 2021 Sep;70:101396. doi: 10.1016/j.arr.2021.101396. Epub 2021 Jun 23.

Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders

Limanaqi F, Busceti CL, Celli R, Biagioni F, Fornai F.

Prog Neurobiol. 2021 Sep;204:102112. doi: 10.1016/j.pneurobio.2021.102112. Epub 2021 Jun 23.

Cerebral Hemodynamic Responses to the Difficulty Level of Ambulatory Tasks in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis

Lin JP, Feng HS, Zhai H, Shen X.

Neurorehabil Neural Repair. 2021 Sep;35(9):755-768. doi: 10.1177/15459683211028548. Epub 2021 Jun 25.

The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study

Yamashita K, Yube Y, Yamazaki Y, Fukuchi T, Kato M, Koike T, Uehara T, Ikeda Y, Furune S, Murakami H, Kubota E, Fujioka S, Sato Y, Jin X, Suzuki T, Furukawa K, Tsuboi Y.

BMC Neurol. 2021 Jun 25;21(1):242. doi: 10.1186/s12883-021-02269-7.

Differentiating Parkinson's disease motor subtypes: A radiomics analysis based on deep gray nuclear lesion and white matter

Sun D, Wu X, Xia Y, Wu F, Geng Y, Zhong W, Zhang W, Guo D, Li C.

Neurosci Lett. 2021 Aug 24;760:136083. doi: 10.1016/j.neulet.2021.136083. Epub 2021 Jun 24.

Mini review - The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease

Rodrigues PS, Kale PP.

Rev Neurol (Paris). 2021 Nov;177(9):1082-1089. doi: 10.1016/j.neurol.2021.01.015. Epub 2021 Jun 24.

Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines

Milane L, Dolare S, Jahan T, Amiji M.

Nanomedicine. 2021 Oct;37:102422. doi: 10.1016/j.nano.2021.102422. Epub 2021 Jun 25.

In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?

Parmar M, Björklund A, Björklund T.

Curr Opin Genet Dev. 2021 Oct;70:76-82. doi: 10.1016/j.gde.2021.06.002. Epub 2021 Jun 24.

The role of immune cells in the course of Parkinson's disease

He XY, Wang RR, Wang TH.

Ibrain. 2021 Jun 28;7(2):146-151. doi: 10.1002/j.2769-2795.2021.tb00077.x. eCollection 2021 Jun.

Aberrant TDP-43 phosphorylation: a key wind gap from TDP-43 to TDP-43 proteinopathy

Huang ZQ, Ba ZS, Huang NQ, Li YY, Luo Y.

Ibrain. 2021 Jun 28;7(2):119-131. doi: 10.1002/j.2769-2795.2021.tb00074.x. eCollection 2021 Jun.

Systemic Literature Review of the Use of Virtual Reality for Rehabilitation in Parkinson Disease

Chau B, Humbert S, Shou A.

Fed Pract. 2021 Apr;38(Suppl 1):S20-S27. doi: 10.12788/fp.0112.

Case Report: De Clerambault's Syndrome in Dementia With Lewy Bodies

Suehiro T, Satake Y, Hashimoto M, Ikeda M.

Front Psychiatry. 2021 Jun 10;12:665868. doi: 10.3389/fpsyt.2021.665868. eCollection 2021.

Wearable Devices for Assessment of Tremor

Vescio B, Quattrone A, Nisticò R, Crasà M, Quattrone A.

Front Neurol. 2021 Jun 11;12:680011. doi: 10.3389/fneur.2021.680011. eCollection 2021.

A case of drug-induced parkinsonism and tardive akathisia with e1143g polymerase γ mutation-innocent bystander or a culprit?

Idiculla PS, Hussain ST, Siddiqui JH.

J Clin Transl Res. 2021 May 14;7(3):297-301. eCollection 2021 Jun 26.

ANXA1 with Anti-Inflammatory Properties Might Contribute to Parkinsonism

Darvish H, Azcona LJ, Taghavi S, Firouzabadi SG, Tafakhori A, Alehabib E, Mohajerani F, Zardadi S, Paisán-Ruiz C.

Ann Neurol. 2021 Aug;90(2):319-323. doi: 10.1002/ana.26148. Epub 2021 Jul 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias